ClinicalTrials.gg
RecruitingNCT06981442Updated Aug 19, 2026

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

An interventional study of Community-based environmental management and Vector control against immature stages of Aedes in Aedes-borne Diseases, sponsored by Institute of Tropical Medicine, Belgium. Recruiting at 1 site in Democratic Republic of the Congo. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Institute of Tropical Medicine, Belgium · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
2,050
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Arboviral diseases are viral diseases transmitted by mosquitoes of the Aedes genus and are constantly spreading throughout the world, constituting a significant threat to public health.

In Africa, there is very little data on the epidemiological situation of Aedes-borne diseases and programs for monitoring these diseases are very limited. In the Democratic Republic of the Congo (DRC), several epidemics of yellow fever, dengue fever, chikungunya and Zika cases have been reported. In particular, in Kinshasa, the dengue and chikungunya viruses have previously been detected in patients with undifferentiated fevers and several studies have shown entomological transmission indices above the criteria and standards of the World Health Organization (WHO).

The aim of our study is to implement and evaluate different strategies to control Aedes mosquitoes at different stages of their life cycle in the city of Kinshasa.

In particular, a before-and-after interventional study will be piloted and tested in the health zone of Kinshasa, with the aim of providing preliminary evidence of the impact of vector control tools.

Interventions will be implemented in 400 households for each arm for 12 months. Before, after and during the interventions, entomological surveys will be conducted in 160 households in each arm to define the density of the vectors. Mosquitoes will be tested for the possible presence of arbovirus RNA (dengue, chikungunya, Zika, yellow fever). During the pre-intervention period, a serological survey for the same diseases transmitted by the Aedes mosquito will be conducted on a sample of 450 people included in two health centers of reference for the health zone of Mont Ngafula 1. A questionnaire will also be administered before and after the intervention implementation to assess the community's knowledge, attitudes and practices towards Aedes mosquito vector control and Aedes-borne diseases.

The integration of the data collected within the scope of this study will provide an assessment of the feasibility and impact of the tested methods on entomological indicators, as well as determining the exposure and knowledge of Aedes-borne diseases in the Mont Ngafula 1 area.

Read the detailed description

Arboviral diseases are viral diseases transmitted by mosquitoes of the Aedes genus and are constantly spreading throughout the world, constituting a significant threat to public health. In the last 30 years, the frequency and extent of Aedes-borne epidemics have increased significantly and the main vectors, Aedes aegypti and Aedes albopictus, have expanded their geographical distribution worldwide.

In Africa, there is very little data on the epidemiological situation of Aedes-borne diseases and programs for monitoring these diseases are very limited. In the Democratic Republic of the Congo (DRC), several epidemics of yellow fever, dengue fever, chikungunya and Zika cases have been reported. In particular, in Kinshasa, the dengue and chikungunya viruses have previously been detected in patients with undifferentiated fevers and several studies have shown entomological transmission indices above the criteria and standards of the World Health Organization (WHO). However, vector control activities for Aedes are not carried out regularly outside of epidemic periods and the need for targeted strategies remains essential.

The aim of our study is to implement and evaluate different strategies to control Aedes mosquitoes at different stages of their life cycle in the city of Kinshasa. Furthermore, the integration of a serological survey on diseases transmitted by the Aedes vector will strengthen our knowledge on the circulation of these diseases in the area, for which the data in the literature remain fragmentary until now.

In particular, a before-and-after interventional study will be piloted and tested in the health zone of Mont Ngafula 1, Kinshasa, which is characterized by ecological diversity and a known history of arbovirus circulation. In this pilot study, with the aim of providing preliminary evidence of the impact of vector control tools, there are four arms: i) community-based environmental management approach, ii) community-based environmental management and vector control against immature stages of Aedes (pyriproxifen-based autodissemination stations), iii) community-based environmental management and vector control against the mature stages of Aedes aegypti (mass trapping using BG-GAT - Gravid Aedes Traps), iv) control arm without implementation of vector control interventions. These interventions will be implemented in 400 households for each arm for 12 months. Before, after and during the interventions, entomological surveys will be conducted in 160 households in each arm to define the density of the vectors. Mosquitoes will be tested for the possible presence of arbovirus RNA (dengue, chikungunya, Zika, yellow fever). During the pre-intervention period, a serological survey for the same diseases transmitted by the Aedes mosquito will be conducted on a sample of 450 people included in two health centers of reference for the health zone of Mont Ngafula 1. The knowledge, attitudes and practices of the subjects belonging to the households enrolled in the study will be collected using an electronic questionnaire before and after the intervention. The integration of the data collected within the scope of this study will provide an assessment of the feasibility and impact of the tested methods on entomological indicators, as well as determining the exposure and knowledge of Aedes-borne diseases in the Mont Ngafula 1 area, for a better definition of the next measures to be adopted in the fight against vectors, tailored to the specific context of the the DRC.

02

Conditions studied

  • Aedes-borne Diseases

Keywords

  • Vector control
  • Aedes mosquitoes
  • Democratic Republic of the Congo
03

In context

Lead sponsor

Institute of Tropical Medicine, Belgium is the lead sponsor of 104 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

At household level:

Inclusion Criteria:

  • Belong to a household in one of the 4 health areas selected as study arms
  • From 18 years of age to consent for household enrollment and participation in the serosurvey
  • Consenting

Exclusion Criteria:

  • Not belong to a household in one of the 4 health areas selected as study arms
  • Under 18 years of age
  • Non-consenting

At health facility level:

Inclusion Criteria:

  • From 18 years of age
  • Resident of the health zone of Mont Ngafula 1
  • Consenting

Exclusion Criteria:

  • Under 18 years of age
  • Not resident in the health zone of Mont Ngafula 1
  • Seriously ill and hospitalized, requiring transfusion, presence of blood clotting disorders, allergies resulting from injections, adverse events associated with previous blood sampling, pregnancy
  • Non-consenting
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,050 participants (estimated)

Study arms

  • Experimental
    ARM 1_Community-based environmental management

    This intervention will be carried out by the community, who will have received training and information on the environmental management measures suitable for controlling the Aedes mosquito. It will involve a cluster of 400 households randomly assigned to this intervention.

    Behavioral: Community-based environmental management

  • Experimental
    ARM 2_Community-based environmental management AND vector control against immature stages of Aedes

    This intervention combines community-based environmental management (specified in the first study arm) with vector control against immature stages of Aedes. It will involve a cluster of 400 households randomly assigned to this intervention.

    Behavioral: Community-based environmental management · Other: Vector control against immature stages of Aedes

  • Experimental
    ARM 3_Community-based environmental management AND vector control against mature stages of Aedes

    This intervention combines community-based environmental management (specified in the first arm of the study) with vector control against the mature stages of Aedes. It will involve a cluster of 400 households randomly assigned to this intervention.

    Behavioral: Community-based environmental management · Other: Vector control against the mature stages of Aedes

  • No intervention
    ARM 4_Control arm

    No control interventions will be implemented. It will involve a cluster of 400 households randomly assigned to this arm.

Interventions

  • BehavioralCommunity-based environmental management

    This intervention will be performed by the local community, who will have been previously informed and trained on the appropriate environmental management methods for the control of the Aedes mosquito. It will be based on the following elements: i) identification and removal of all artificial sources of reproduction of the Aedes mosquito inside and around the house (i.e. covering abandoned containers and/or storage containers to avoid water accumulation); ii) regular collection and disposal of household waste; iii) identification and resolution of all artificial sources of reproduction of the Aedes vector in or around the house (i.e. natural cavities such as tree holes will be filled to prevent water accumulation). This intervention will be carried out as a single intervention in Arm 1, in combination with a larvicidal intervention in Arm 2 and in combination with the intervention against the adult stage of the Aedes mosquito in Arm 3.

  • OtherVector control against immature stages of Aedes

    Larvicidal control will be carried out through pyriproxifen-based autodissemination stations combined with Beauveria bassiana, implemented according to the manufacturer's recommended procedures.

  • OtherVector control against the mature stages of Aedes

    The control of the adult Aedes mosquitoes will be carried out through mass trapping using BG-GAT traps implemented according to the manufacturer's recommended procedures. In each household, three traps will be deployed.

06

What researchers measure

Primary outcomes

  1. Adult mosquito collection - Entomological Indicator

    Adult mosquitoes will be collected outdoor using Prokopack mosquito aspirator in 50 households at the center of each of the 4 study arms and using BG-Sentinel traps in 10 households at the center of each of the 4 study arms. Adult mosquitoes obtained through BG-GAT traps in Arm 3 will also be collected.

    Time frame: Six collections in total: 1 at baseline, 4 during the intervention (one per trimester), 1 three months after completion of the intervention.

  2. Mosquito larval survey - Entomological Indicator

    Larval surveys will be carried out in 100 households at the center of each of the 4 study arms. Immature mosquitoes obtained through the auto-dissemination stations in Arm 2 will also be collected.

    Time frame: Six collections in total: 1 at baseline, 4 during the intervention (one per trimester), 1 three months after completion of the intervention.

  3. Epidemiological indicator

    A sero-survey prospectively including 450 consenting subjects will be carried out in two hospitals in the health zone of Mont Ngafula 1, Kinshasa. The blood sample will be tested for antibodies against the main arboviruses (Yellow Fever, Dengue, Chikungunya, Zika). De-identified socio-demographic data will be collected.

    Time frame: Once : before/at beginning of intervention

Secondary outcomes

  1. Knowledge, attitudes, and practices.

    A survey on knowledge, practices and behaviors regarding Aedes-borne diseases, Aedes mosquitoes and vector control will be proposed to 100 subjects for each study arm, for a total of 400 participants.

    Time frame: Twice in total: at the beginning of the study and three months after completion of the intervention.

07

Study locations

1 of 1 sites recruiting
  • Institut National de Recherche Biomédicale, INRB
    Kinshasa, République Démocratique Du Congo, Democratic Republic of the Congo
    Recruiting
08

References and documents

Publications

  • Mbanzulu KM, Wumba R, Mukendi JK, Zanga JK, Shija F, Bobanga TL, Aloni MN, Misinzo G. Mosquito-borne viruses circulating in Kinshasa, Democratic Republic of the Congo. Int J Infect Dis. 2017 Apr;57:32-37. doi: 10.1016/j.ijid.2017.01.016. Epub 2017 Jan 30. PubMed 28153792 ↗
  • Proesmans S, Katshongo F, Milambu J, Fungula B, Muhindo Mavoko H, Ahuka-Mundeke S, Inocencio da Luz R, Van Esbroeck M, Arien KK, Cnops L, De Smet B, Lutumba P, Van Geertruyden JP, Vanlerberghe V. Dengue and chikungunya among outpatients with acute undifferentiated fever in Kinshasa, Democratic Republic of Congo: A cross-sectional study. PLoS Negl Trop Dis. 2019 Sep 5;13(9):e0007047. doi: 10.1371/journal.pntd.0007047. eCollection 2019 Sep. PubMed 31487279 ↗
  • Selhorst P, Makiala-Mandanda S, De Smet B, Marien J, Anthony C, Binene-Mbuka G, De Weggheleire A, Ilombe G, Kinganda-Lusamaki E, Pukuta-Simbu E, Lubula L, Mbala-Kingebeni P, Nkuba-Ndaye A, Vogt F, Watsenga F, Van Bortel W, Vanlerberghe V, Arien KK, Ahuka-Mundeke S. Molecular characterization of chikungunya virus during the 2019 outbreak in the Democratic Republic of the Congo. Emerg Microbes Infect. 2020 Dec;9(1):1912-1918. doi: 10.1080/22221751.2020.1810135. PubMed 32787529 ↗
  • Willcox AC, Collins MH, Jadi R, Keeler C, Parr JB, Mumba D, Kashamuka M, Tshefu A, de Silva AM, Meshnick SR. Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2018 Sep;99(3):756-763. doi: 10.4269/ajtmh.18-0156. Epub 2018 Jul 5. PubMed 29988000 ↗
  • Weetman D, Kamgang B, Badolo A, Moyes CL, Shearer FM, Coulibaly M, Pinto J, Lambrechts L, McCall PJ. Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future Threats. Int J Environ Res Public Health. 2018 Jan 28;15(2):220. doi: 10.3390/ijerph15020220. PubMed 29382107 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Sep 2026, 18 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2025
First posted
May 20, 2025
StartActual
Mar 26, 2025
Primary completionEst.
Sep 30, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06981442
Collaborators
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Responsible party
Sponsor
First posted
May 20, 2025
Start date
Mar 26, 2025
Primary completion
Sep 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 19, 2026

Study contacts

Luciana Lepore
Contact
llepore@itg.be
+32(0)32476666
Wim Van Bortel
Contact
wvanbortel@itg.be
+32(0)32476666
Veerle Vanlerberghe
principal investigator · Institute of Tropical Medicine Antwerp

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion